MDPEP

MDPEP
Legal status
Legal status	DE: Anlage II (Authorized trade only, not prescriptible); UK: Class B;
Identifiers
	IUPAC name 1-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-ylheptan-1-one;
CAS Number	746541-09-3 ; 24646-39-7 (HCl);
PubChem CID	132520294;
ChemSpider	95753889;
UNII	L6IDR88RVF;
Chemical and physical data
Formula	C18H25NO3
Molar mass	303.402 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCCCC(C(=O)C1=CC2=C(C=C1)OCO2)N3CCCC3;
	InChI InChI=1S/C18H25NO3/c1-2-3-4-7-15(19-10-5-6-11-19)18(20)14-8-9-16-17(12-14)22-13-21-16/h8-9,12,15H,2-7,10-11,13H2,1H3; Key:APQUWEZHVKBPTI-UHFFFAOYSA-N;

MDPEP (also known as MD-PV8 and MDPHPP) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug. It is the longer chain heptyl homologue of the well known stimulant designer drugs MDPV and MDPHP. It was first identified in Sweden in 2019 and has been relatively widely sold, being the most commonly encountered substituted cathinone derivative found in the US in 2020–2021, though it has still not reached the same levels of use internationally as MDPV and MDPHP.^[1]^[2]^[3]